Aspiro Pharma Limited Pharmaceutical Export Profile — India (DGFT 2022–2026)

Name: Aspiro Pharma Limited Pharmaceutical Export Portfolio Dataset — 3 Products, $8.0M FOB USD, India (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Aspiro Pharma Limited — Pharmaceutical Exporter Profile (2026) | 3 Products, $8.0M Trade | TransData Nexus

Aspiro Pharma Limited

Indian Pharmaceutical Exporter · Antibiotics Specialist · $8.0M Total Trade · DGFT Verified

Aspiro Pharma Limited is an Indian pharmaceutical exporter with a total trade value of $8.0M across 3 products in 3 therapeutic categories. Based on 234 verified export shipments from Indian Customs (DGFT) records, the company actively competes across multiple product segments. Top exports include Vancomycin ($5.4M), Voriconazole ($1.4M), Ketorolac ($1.2M).

Aspiro Pharma Limited — Export Portfolio & Destination Treemap

Aspiro Pharma Limited pharmaceutical export portfolio — 3 products across 3 therapeutic categories. Source: Indian Customs (DGFT).

Who is Aspiro Pharma Limited? — Company Overview & Market Position

Aspiro Pharma Limited, established in 2012, is a rapidly growing Indian pharmaceutical company specializing in the research, development, and manufacturing of generic parenteral formulations. The company is headquartered in Hyderabad, Telangana, India, with its corporate office located at Plot No.23, Survey No.321, Biotech Park Phase-III, Karkapatla Village, Siddipet District – 502281.

Aspiro Pharma Limited is a public unlisted company, incorporated on 5 February 2014, with a Corporate Identification Number (CIN) of U24100TG2014PLC092771. The company is classified as a non-government company limited by shares. As of the latest available data, Aspiro Pharma Limited has an authorized capital of ₹415 crore and a paid-up capital of ₹404.15 crore.

The company employs between 1,001 and 5,000 individuals, reflecting its significant presence in the pharmaceutical manufacturing sector. Aspiro Pharma Limited's official website is www.aspiropharma.com, providing comprehensive information about its products, services, and corporate updates.

What Does Aspiro Pharma Limited Export? — Product Portfolio Analysis

Top Products by Export Value

1Vancomycin$5.4M

Product Portfolio — Top 3 by Export Value

Aspiro Pharma Limited exports 3 pharmaceutical products across 3 therapeutic categories.

#	Product	Category	Export Value	Shipments	Market Share	Rank
1	Vancomycin	Antibiotics	$5.4M	149	5.8%	6
2	Voriconazole	Advanced Antifungals	$1.4M	59	4.5%	6
3	Ketorolac	Analgesics & Antipyretics	$1.2M	26	1.0%	7

Aspiro Pharma Limited exports 3 pharmaceutical products across 3 therapeutic categories with a total export value of $8.0M. The top category is Antibiotics (67.5% of portfolio), followed by Advanced Antifungals (17.6%), indicating a concentrated portfolio with the top 5 products accounting for 100.0% of total export value.

Aspiro Pharma Limited — Corporate Profile & Information

Headquarters, ownership, manufacturing facilities, and key leadership

1Corporate Overview

2Manufacturing Facilities

Aspiro Pharma Limited operates a state-of-the-art manufacturing facility located at Plot No.23, Survey No.321, Biotech Park Phase-III, Karkapatla Village, Siddipet District – 502281, Telangana, India. The facility specializes in the production of generic parenteral formulations, including injectables, ophthalmics, pre-filled syringes (PFS), and IV bags. These products are designed to treat a wide range of ailments, demonstrating the company's commitment to addressing diverse therapeutic needs.

3Key Leadership

As of the latest available information, Aspiro Pharma Limited's leadership includes:

Bandi Vamsikrishna: Director
Parthasaradhi Reddy Bandi: Director
Gopala Krishna Rampalli: Director
Khadgapathi Podile: Director
Buchiram Venkat Sobhanadri Suri: Director
Krishnaveni Kura: Director

These individuals bring a wealth of experience and expertise to the company's strategic direction and operations.

TransData Nexus Research · Government registries, company filings, regulatory databasesMar 2026

Where Does Aspiro Pharma Limited Export? — Destination Intelligence

Regulated market presence, emerging market penetration, and geographic strategy

1Regulated Markets

Aspiro Pharma Limited has made significant strides in obtaining regulatory approvals for its products in various international markets. The company's manufacturing facility has received Good Manufacturing Practice (GMP) certifications from several regulatory bodies, including:

Ukraine Medicines and Drug Control: GMP Certificate
ANVISA Brazil: GMP Certificate
UAE Ministry of Health: GMP Certificate
INVIMA Colombia: GMP Certificate

These certifications underscore Aspiro Pharma Limited's commitment to maintaining high-quality manufacturing standards and its readiness to meet the stringent requirements of regulated markets.

2Emerging Markets

Aspiro Pharma Limited has strategically positioned itself to penetrate emerging markets, including regions in Africa, Latin America, and Southeast Asia. The company's adherence to international quality standards, as evidenced by its GMP certifications from various regulatory bodies, facilitates its entry into these markets. By leveraging these certifications, Aspiro Pharma Limited aims to expand its global footprint and provide access to high-quality medicines in underserved regions.

Aspiro Pharma Limited — Manufacturing & Regulatory Profile

FDA status, WHO-GMP certification, EU GMP compliance, and regulatory track record

1FDA Status

As of the latest available information, Aspiro Pharma Limited has not publicly disclosed specific details regarding its FDA facility registrations, approved Abbreviated New Drug Applications (ANDAs), Drug Master File (DMF) filings, or inspection history. This lack of publicly available information may be due to the company's focus on other international markets or the proprietary nature of such data. For the most accurate and up-to-date information, it is recommended to consult the FDA's official database or contact Aspiro Pharma Limited directly.

2WHO & EU GMP

Aspiro Pharma Limited's manufacturing facility has received GMP certifications from several international regulatory bodies, including the Ukraine Medicines and Drug Control, ANVISA Brazil, UAE Ministry of Health, and INVIMA Colombia. These certifications attest to the company's adherence to international quality standards. However, as of the latest available information, there is no public record of Aspiro Pharma Limited obtaining WHO prequalification or EU GMP certificates. For the most current information, it is advisable to consult the official websites of the World Health Organization and the European Directorate for the Quality of Medicines & HealthCare.

CDSCO & Indian Regulatory

Aspiro Pharma Limited — Competitive Positioning Among Indian Pharma Exporters

Market share comparison, key differentiators, and strategic analysis

1Competitive Landscape

Aspiro Pharma Limited operates in a competitive landscape, with several key players in the generic parenteral formulations market. While specific market share data is not publicly available, the company's focus on high-quality manufacturing, as evidenced by its GMP certifications from multiple international regulatory bodies, positions it favorably in the market. Additionally, Aspiro Pharma Limited's strategic expansion into emerging markets demonstrates its commitment to growth and competitiveness.

2Key Differentiators

Aspiro Pharma Limited's key differentiators include its dedicated focus on generic parenteral formulations, a diverse product portfolio spanning multiple therapeutic categories, and adherence to international quality standards as demonstrated by its GMP certifications. The company's strategic expansion into emerging markets further enhances its competitive edge, enabling it to provide high-quality medicines to a broader global audience.

3Strategic Position

Aspiro Pharma Limited's current strategic direction emphasizes the development and manufacturing of generic parenteral formulations, with a focus on injectables, ophthalmics, pre-filled syringes (PFS), and IV bags. The company's adherence to international quality standards and its expansion into emerging markets reflect a strategic vision aimed at global growth and accessibility. Looking ahead, Aspiro Pharma Limited is well-positioned to leverage its strengths in R&D, manufacturing, and regulatory compliance to achieve sustained success in the pharmaceutical industry.

Buyer Due Diligence Brief — Evaluating Aspiro Pharma Limited as a Supplier

Track record assessment, certifications to verify, and pre-order checks

1Supplier Assessment

Aspiro Pharma Limited has demonstrated a strong track record in manufacturing and exporting generic parenteral formulations. The company's export portfolio includes products across multiple therapeutic categories, with a total export value of $8.0 million USD and 234 shipments. The top three products exported are Vancomycin ($5.4 million, 5.8% market share), Voriconazole ($1.4 million, 4.5% market share), and Ketorolac ($1.2 million, 1.0% market share). This diverse product range and consistent export activity indicate a reliable and capable supplier.

2Certifications to Verify

Importers should verify the following certifications when considering Aspiro Pharma Limited as a supplier:

FDA Facility Registration: Confirm the company's registration status with the U.S. Food and Drug Administration.
WHO-GMP Certification: Verify the company's adherence to World Health Organization Good Manufacturing Practice standards.
EU GMP Certification: Ensure the company complies with European Union Good Manufacturing Practice standards.

Frequently Asked Questions — Aspiro Pharma Limited

How many pharmaceutical products does Aspiro Pharma Limited export from India?

Aspiro Pharma Limited exports 3 pharmaceutical products across 3 therapeutic categories. The top exports are Vancomycin ($5.4M), Voriconazole ($1.4M), Ketorolac ($1.2M). Total export value is $8.0M.

What is Aspiro Pharma Limited's total pharmaceutical export value?

Aspiro Pharma Limited's total pharmaceutical export value is $8.0M, based on 234 verified shipments recorded in Indian Customs (DGFT) data.

What therapeutic categories does Aspiro Pharma Limited cover?

Aspiro Pharma Limited exports across 3 therapeutic categories. The largest are Antibiotics (67.5%, 1 products), Advanced Antifungals (17.6%, 1 products), Analgesics & Antipyretics (14.9%, 1 products).

Get Full Aspiro Pharma Limited Export Intelligence

Access shipment-level details, pricing data, buyer connections, product breakdown, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify manufacturer licensing, GMP certification, and export registration with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports per product category. For current shipment-level data, contact TransData Nexus.